Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ambarish Pandey

Showing results (41-50 of 515) with videos related to

Pageof 52
Sort By:
Circulation|July 25, 2022
Should Polypills Be Used for Heart Failure With Reduced Ejection Fraction?Ambarish Pandey, Neil Keshvani, Thomas J Wang
European Journal of Heart Failure|September 13, 2023
From prediction to prevention: The role of heart failure risk models: Heart to Heart: The Promise and Pitfalls of Heart Failure Risk Prediction ModelsMatthew W Segar, Neil Keshvani, Ambarish Pandey
European Journal of Preventive Cardiology|June 27, 2025
Metabolic Insights into Heart Failure Prevention: The Role of Ketone Bodies in Multi-Marker Risk AssessmentJuan David Coellar, Neil Keshvani, Ambarish Pandey
JACC. Heart Failure|July 30, 2021
Reply: Alternative Models of Cardiac Rehabilitation Delivery Urgently Needed to Improve Access for Heart Failure PatientsNeil Keshvani, Ambarish Pandey, Gregg C Fonarow
Progress in Cardiovascular Diseases|October 1, 2020
Diagnostic and prognostic considerations for use of natriuretic peptides in obese patients with heart failureShruti Singh, Ambarish Pandey, Ian J Neeland
JAMA|September 1, 2018
Errors Resulting From Standard Order Sets-In ReplyArjun Gupta, Sandeep R Das, Ambarish Pandey
European Journal of Heart Failure|October 9, 2018
Developing evidence-based and accountable health policy in heart failureCian P McCarthy, Muthiah Vaduganathan, Ambarish Pandey
Journal of the American Geriatrics Society|June 19, 2021
Physical frailty in older patients with acute heart failure: From risk marker to modifiable treatment targetAmbarish Pandey, Olivia Gilbert, Dalane W Kitzman
Journal of the American College of Cardiology|May 14, 2025
Individual Variability in the Cardiometabolic Response to Tirzepatide: Moving Beyond the AverageSafi U Khan, Ambarish Pandey, Khurram Nasir
Trends in Cardiovascular Medicine|January 9, 2018
Editorial commentary: Obesity and heart failure with preserved ejection fraction: A single disease or two co-existing conditions?Salvatore Carbone, Ambarish Pandey, Carl J Lavie
Pageof 52

Showing results (41-50 of 515) with videos related to

Sort By:
Pageof 52
Circulation|July 25, 2022
Should Polypills Be Used for Heart Failure With Reduced Ejection Fraction?Ambarish Pandey, Neil Keshvani, Thomas J Wang
European Journal of Heart Failure|September 13, 2023
From prediction to prevention: The role of heart failure risk models: Heart to Heart: The Promise and Pitfalls of Heart Failure Risk Prediction ModelsMatthew W Segar, Neil Keshvani, Ambarish Pandey
European Journal of Preventive Cardiology|June 27, 2025
Metabolic Insights into Heart Failure Prevention: The Role of Ketone Bodies in Multi-Marker Risk AssessmentJuan David Coellar, Neil Keshvani, Ambarish Pandey
JACC. Heart Failure|July 30, 2021
Reply: Alternative Models of Cardiac Rehabilitation Delivery Urgently Needed to Improve Access for Heart Failure PatientsNeil Keshvani, Ambarish Pandey, Gregg C Fonarow
Progress in Cardiovascular Diseases|October 1, 2020
Diagnostic and prognostic considerations for use of natriuretic peptides in obese patients with heart failureShruti Singh, Ambarish Pandey, Ian J Neeland
JAMA|September 1, 2018
Errors Resulting From Standard Order Sets-In ReplyArjun Gupta, Sandeep R Das, Ambarish Pandey
European Journal of Heart Failure|October 9, 2018
Developing evidence-based and accountable health policy in heart failureCian P McCarthy, Muthiah Vaduganathan, Ambarish Pandey
Journal of the American Geriatrics Society|June 19, 2021
Physical frailty in older patients with acute heart failure: From risk marker to modifiable treatment targetAmbarish Pandey, Olivia Gilbert, Dalane W Kitzman
Journal of the American College of Cardiology|May 14, 2025
Individual Variability in the Cardiometabolic Response to Tirzepatide: Moving Beyond the AverageSafi U Khan, Ambarish Pandey, Khurram Nasir
Trends in Cardiovascular Medicine|January 9, 2018
Editorial commentary: Obesity and heart failure with preserved ejection fraction: A single disease or two co-existing conditions?Salvatore Carbone, Ambarish Pandey, Carl J Lavie
Pageof 52